Pancreatic Cancer Clinical Trials

A look at the following clinical trial: Studying Biomarkers in Patients With Pancreatic Cancer

A look at the following clinical trial: Pancreatic Cancer Genetic Epidemiology (PACGENE) Study

A look at the following clinical trial: Vaccine Study for Surgically Resected Pancreatic Cancer

Provides information to potential participants on the following clinical trial: APRiCOT-P: Study to Evaluate the Safety and Efficacy of Apricoxib With Gemcitabine and Erlotinib in the Treatment of Patients With Advanced Pancreatic Cancer (TP2001-203)

Provides information to potential participants on the following clinical trial: Phase II Study of Coagulation Factor VIIa Inhibitor PCI-27483 in Pancreatic Cancer Patients Receiving Treatment With Gemcitabine, Part A

Provides information to potential participants on the following clinical trial: Phase I Study of Low-Dose Fractionated Radiotherapy as a Chemosensitizer for Gemcitabine and Erlotinib in Patients With Locally Advanced or Limited Metastatic Pancreatic Cancer

Provides information to potential participants on the following clinical trial: A Phase 1b/2 Study to Evaluate the Safety and Efficacy of AMG 655 or AMG 479 in Combination With Gemcitabine as First-Line Therapy for Metastatic Pancreatic Cancer

Provides information to potential participants on the following clinical trial: Phase II Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF) in Gemcitabine-Refractory Advanced Pancreatic Cancer